Alzheimers

Proteins in the blood can be used to gauge a person’s risk for cerebral small vessel disease, which affects millions of older adults.

Identifying the characteristics of dementia that are caused by traumatic brain injury could prevent people from being misdiagnosed with Alzheimer’s disease.

A multi-disciplinary group of all-star researchers has been brought together thanks to a gift from philanthropists David and Diane Steffy.

Their findings could lead to new methods to get the body's repair enzyme to work better.

The research, conducted at the UCLA Alzheimer’s and Dementia Care Program, also shows that the program was cost-neutral after accounting for its costs.

The study is the most comprehensive published effort to date to identify the source of neurodegeneration across species.

The research by Dr. Lin Jiang and his team included findings from computer software that assisted them in the drug selection process.

The study not only revealed the promise of goal attainment in dementia care, but also the importance of goal setting for caregivers, who are affected both emotionally and physically by their loved one’s illness.

Neurophysicist Mayank Mehta’s work has implications for diagnosing and treating neurological diseases.

The research “may reassure some people that despite testing positive on screening tests, their chances of developing Alzheimer’s disease dementia is low,” said UCLA’s Ron Brookmeyer.

UCLA research provides critical knowledge for medicinal chemists to begin designing new drugs based on cambinol that are more potent than the molecule itself.

“This new tool makes possible experiments that we have been wanting to perform for many years,” said UCLA professor Baljit Khakh.

The scientists have shown in their research on mice that increasing levels of a protein could make immune cells more effective at fighting disease.

If replicated in larger studies, the findings could lead to new types of programs to improve mental agility in older adults by combining mental training with physical fitness.

UCLA geneticist Dr. Wayne Grody UCLA geneticist says many people are ill-equipped to handle troubling medical information without the guidance of physicians.

Protein-imaging method developed by new UCLA researcher overcomes challenges of current techniques, offering untold potential in the exploration of disease and treatment.

A UCLA study has found that moderate daily walks improve attention and mental skills for adults ages 60 and older.

47 million Americans already demonstrate some evidence of susceptibility to the disease.

The scientists believe the technique, which focuses on cells’ mitochondria, could eventually lead to a way to delay the onset of Parkinson’s disease, Alzheimer’s disease and cancer.

"“Dementia is an isolating disease that can bring on loneliness and is often void of opportunities for social interactions,” says Dr. Zaldy Tan, UCLA gerontologist and director of TimeOut @ UCLA.

UCLA Health offers training to teach skills and techniques that help family members confidently care for a loved one who has dementia.

UCLA School of Nursing researchers found that people with a certain genetic variation who took donepezil for the condition had a faster cognitive decline than those who took a placebo.

The discovery could have important implications for treating white matter strokes, a major cause of dementia that also accelerate Alzheimer’s disease.

Neuroscientists at UCLA have developed a new technique for studying a particular type of cell in the brain known as an astrocyte that may play a role in diseases such as Lou Gehrig’s disease and Alzheimer's disease.

UCLA researchers note that the next decade shows great promise for things like improving food safety, fighting infections, storing energy and supplying clean energy.